Agios Pharmaceuticals, Inc. (AGIO)

Healthcare · Biotechnology · NASDAQ

Agios Pharmaceuticals, Inc. (AGIO) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $1.93B and a free-cash-flow yield of -20.7%. Over the most recent reported fiscal year, revenue grew 48.0%.

Market cap	$1.93B
Trailing P/E	—
FCF yield	-20.7%
Revenue growth (YoY)	+48.0%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live AGIO data on Nama Insights →

Recent Congressional trades

Agios Pharmaceuticals, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Gilbert Cisneros	House	Buy	$1,001 - $15,000	Apr 6, 2026
Josh Gottheimer	House	Buy	$1,001 - $15,000	Feb 7, 2024
Thomas MacArthur	House	Sell	$1,001 - $15,000	Jun 1, 2015